Download PDF
Thromb Haemost 2008; 99(06): 1134-1136
DOI: 10.1160/TH08-02-0064
Letters to the Editor
Schattauer GmbH

Cardiac biomarkers in pulmonary embolism

Giuseppe Lippi
1   Sezione di Chimica e Clinica, Dipartimento di Patologia, Università di Verona, Italy
,
Emmanuel J. Favaloro
2   Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia
› Author Affiliations
Further Information

Publication History

Received 03 February 2008

Accepted after major revision 27 March 2008

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Gibson NS, Sohne M, Kruip MJ. et al on behalf of the Christopher study investigators. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008; 99: 229-234.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Brill-Edwards P, Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb Haemost 1999; 82: 688-694.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Perrier A, Bounameaux H. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost 2001; 86: 475-487.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Arnason T, Wells PS, Forster AJ. Appropriateness of diagnostic strategies for evaluating suspected venous thromboembolism. Thromb Haemost 2007; 97: 195-201.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Health care guideline: Venous thromboembolism. Institute for Clinical Systems Improvement. Revised February 2006. Available at www.icsi.org Accessed on January 30, 2008.
    PubMedGoogle Scholar
  • 6 Qaseem A, Snow V, Barry P. et al Joint American Academy of Family Physicians/American College of Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2007; 146: 454-458.
    CrossrefPubMedGoogle Scholar
  • 7 Constans J, Salmi LR, Sevestre-Pietri MA. et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99: 202-207.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Palla A, Bardi G, Ribas C. Diagnosis of pulmonary embolism. Semin Thromb Hemost 2006; 32: 822-830.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Lippi G, Guidi GC. The power of negative thinking. Am J Emerg Med. 2008 in press.
    PubMedGoogle Scholar
  • 10 Giannitsis E, Katus HA. Risk stratification in pulmonary embolism based on biomarkers and echocardiography. Circulation 2005; 112: 1520-1521.
    CrossrefPubMedGoogle Scholar
  • 11 Fromm Jr. RE. Cardiac troponins in the intensive care unit: common causes of increased levels and interpretation. Crit Care Med 2007; 35: 584-588.
    CrossrefPubMedGoogle Scholar
  • 12 Tulevski II, Hirsch A, Sanson BJ. et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 2001; 86: 1193-1196.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Kucher N, Goldhaber SZ. Risk stratification of acute pulmonary embolism. Semin Thromb Hemost 2006; 32: 838-847.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.
    CrossrefPubMedGoogle Scholar
  • 15 Konstantinides S, Geibel A, Olschewski M. et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-1268.
    CrossrefPubMedGoogle Scholar
  • 16 Kucher N, Wallmann D, Carone A. et al. Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism. Eur Heart J 2003; 24: 1651-1656.
    CrossrefPubMedGoogle Scholar
  • 17 Scridon T, Scridon C, Skali H. et al. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96: 303-305.
    CrossrefPubMedGoogle Scholar
  • 18 Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-2368.
    CrossrefPubMedGoogle Scholar
  • 19 Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108: 2191-2194.
    CrossrefPubMedGoogle Scholar
  • 20 Tulevski II, ten Wolde M, van Veldhuisen DJ. et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 2007; 116: 161-166.
    CrossrefPubMedGoogle Scholar
  • 21 Bochowicz A, Kostrubiec M, Pruszczyk P. Serum myoglobin in pulmonary embolism. Circulation 2004; 109: e194.
    CrossrefPubMedGoogle Scholar
  • 22 Turedi S, Gunduz A, Mentese A. et al. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007; 25: 770-773.
    CrossrefPubMedGoogle Scholar
  • 23 Kaczyñska A, Pelsers MM, Bochowicz A. et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 2006; 371: 117-123.
    CrossrefPubMedGoogle Scholar
  • 24 Puls M, Dellas C, Lankeit M. et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 2007; 28: 224-229.
    PubMedGoogle Scholar
  • 25 Harrison A, Amundson S. Evaluation and management of the acutely dyspneic patient: the role of biomarkers. Am J Emerg Med 2005; 23: 371-378.
    CrossrefPubMedGoogle Scholar